The functional transformation of cytotoxic lymphocytes into T-suppressors under the influence of two mediators.
Anfalova. T V TV; Galaktionov. V G VG; Brondz. B D BD
Key Findings
- Thymosin‑alpha‑1 at high levels makes cytotoxic T cells enter a reversible anergic state
- Anergic T cells can acquire suppressor activity after the transition
- The effect was seen in mouse CTL lines interacting with the H‑2Kb molecule
Practical Outcomes
- For most biohackers, this research doesn’t provide a usable protocol or dosage for improving health or performance. It simply indicates that thymosin‑alpha‑1 can modulate immune activity in specific lab conditions, so any real‑world use would be experimental and unproven.
Summary
The study shows that the peptide thymosin‑alpha‑1 can temporarily turn active killer immune cells into a less active, suppressor‑like state, but only when used at high concentrations in a lab setting. This effect is reversible and was observed in mouse cells, not humans.
Abstract
A set of CTL-lines in the system differing in the whole H-2 complex, as well as in distinct subregions of H-2, was established. These lines were routinely tested in Cr51-release assay to insure that they retained lytic activity and antigen-specificity. The result of the interaction of CTL with H-2Kb-molecule and alpha1-thymosine was transition of CTL into a reversible state of anergy. A high concentration of alpha1-thymosine is necessary for this transition. Anergic CTL caused specific suppressor activity that is functional if transformation of CTL into T-suppressors took place.
Study Information
pubmed
1997
10.1016/s0165-2478(97)00113-2